Enrique A. Conterno - Feb 21, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Executive Officer, Director
Signature: /s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol: FGEN
Transactions as of: Feb 21, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/23/2023, 07:29 PM
Previous filing: Jan 10, 2023
Next filing: Mar 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Award	$0	+85.3K	+28.87%	$0.00	381K	Feb 21, 2023	Direct	F1
holding	FGEN	Common Stock						27.8K	Feb 21, 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FGEN	Stock Option (Right to Buy)	Award	$0	+143K		$0.00	143K	Feb 21, 2023	Common Stock	143K	$22.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
F2	Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.